Brief: Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement

Revance Therapeutics

09/12/2024 13:36

Dec 9 (Reuters) - Revance Therapeutics Inc  RVNC.O :
    * CROWN LABORATORIES AND REVANCE ENTER INTO AMENDED AND
RESTATED
MERGER AGREEMENT
    * REVANCE THERAPEUTICS INC: CROWN WILL COMMENCE A TENDER
OFFER TO
ACQUIRE ALL OUTSTANDING SHARES OF REVANCE'S COMMON STOCK FOR
$3.10 PER SHARE IN CASH

Source text:  ID: 
Further company coverage:  RVNC.O 

 ((Reuters.Briefs@thomsonreuters.com;))